Published in Eur J Pharmacol on December 19, 1996
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature (1996) 7.15
ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor. Eur J Pharmacol (1986) 2.07
Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Xenobiotica (1979) 2.07
Adenosine receptor subtypes. Trends Pharmacol Sci (1993) 1.99
The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency. Eur J Pharmacol (1987) 1.94
The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci (1998) 1.85
Pharmacological effects of isopolar phosphonate analogues of ATP on P2-purinoceptors in guinea-pig taenia coli and urinary bladder. Br J Pharmacol (1987) 1.36
A study of the purinoceptors mediating contraction in the rat colon. Br J Pharmacol (1990) 1.36
Characterization of P1-purinoceptors on rat duodenum and urinary bladder. Br J Pharmacol (1992) 1.35
Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae. Br J Pharmacol (1992) 1.34
Some pharmacological and biochemical interactions of the enantiomers of adenylyl 5'-(beta, gamma-methylene)-diphosphonate with the guinea-pig urinary bladder. Br J Pharmacol (1984) 1.30
Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br J Pharmacol (1982) 1.29
Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets. Br J Pharmacol (1981) 1.25
Subtypes of P2-purinoceptors. Studies using analogues of ATP. Ann N Y Acad Sci (1990) 1.21
L-AMP-PCP, an ATP receptor agonist in guinea-pig bladder, is inactive on taenia coli. Eur J Pharmacol (1985) 1.19
Pharmacological effects of L-AMP-PCP on ATP receptors in smooth muscle. Eur J Pharmacol (1986) 1.19
Effects of purines on the longitudinal muscle of the rat colon. Br J Pharmacol (1992) 1.17
The ontogeny of purinoceptors in rat urinary bladder and duodenum. Br J Pharmacol (1990) 1.16
Passage of Japanese encephalitis virus in HeLa cells results in attenuation of virulence in mice. J Gen Virol (1995) 1.13
5'-N-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation. Br J Pharmacol (1981) 1.12
Direct effects of adenylyl 5'-(beta,gamma-methylene)diphosphonate, a stable ATP analogue, on relaxant P1-purinoceptors in smooth muscle. Br J Pharmacol (1991) 1.11
Characterization of adenosine receptors in the rat isolated aorta. Gen Pharmacol (1994) 1.10
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol (2007) 1.10
Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate. Br J Pharmacol (1982) 1.09
Activation of multiple sites by adenosine analogues in the rat isolated aorta. Br J Pharmacol (1996) 1.04
Ontogenesis of proenkephalin products in rat striatum and the inhibitory effects of low-level lead exposure. Brain Res (1985) 1.04
Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets. Br J Pharmacol (1993) 1.03
Low-level lead exposure alters morphine antinociception in neonatal rats. Toxicol Lett (1984) 1.03
Differential effects of suramin on P2-purinoceptors mediating contraction of the guinea-pig vas deferens and urinary bladder. Br J Pharmacol (1994) 1.02
Characterization of P1-purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae. Br J Pharmacol (1996) 0.99
Quantitative autoradiography of mu-,delta- and kappa1 opioid receptors in kappa-opioid receptor knockout mice. Brain Res (1999) 0.99
Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate. Br J Pharmacol (1982) 0.97
Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets. Br J Pharmacol (1981) 0.97
Characterization of adenosine receptors on rat ileum, ileal longitudinal muscle and muscularis mucosae. Eur J Pharmacol (1997) 0.96
Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand. Eur J Pharmacol (1986) 0.96
The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations. Br J Pharmacol (1994) 0.96
Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. Br J Pharmacol (1992) 0.96
Opioids and respiration. Prog Neurobiol (1989) 0.94
Effects of suramin on contractions of the guinea-pig vas deferens induced by analogues of adenosine 5'-triphosphate. Br J Pharmacol (1995) 0.94
Development of opioid systems: peptides, receptors and pharmacology. Brain Res (1987) 0.94
Decrease of D2 receptor binding but increase in D2-stimulated G-protein activation, dopamine transporter binding and behavioural sensitization in brains of mice treated with a chronic escalating dose 'binge' cocaine administration paradigm. Eur J Neurosci (2008) 0.93
Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience (2003) 0.93
Antinociception opioids and the cholinergic system. Prog Neurobiol (1986) 0.93
Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery. Br J Pharmacol (1997) 0.90
Enzyme-potentiated hyposensitization. 3. Control by sugars and diols of the immunological effect of beta glucuronidase in mice and patients with hay fever. Ann Allergy (1973) 0.89
Lead neurotoxicity: a review of the biochemical, neurochemical and drug induced behavioural evidence. Prog Neurobiol (1984) 0.89
Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice. Eur J Pharmacol (2001) 0.89
Swim-stress-induced antinociception in young rats. Br J Pharmacol (1989) 0.87
Characterization and ontogeny of P1-purinoceptors on rat vas deferens. Br J Pharmacol (1993) 0.87
Different effects of current strength on inhibitory responses of the mouse vas deferens to methionine- and leucine-enkephalin. Br J Pharmacol (1979) 0.86
Contractile effects of uridine 5'-triphosphate in the rat duodenum. Br J Pharmacol (1994) 0.86
Behavioural and biochemical responses to morphine associated with its motivational properties are altered in adenosine A(2A) receptor knockout mice. Br J Pharmacol (2008) 0.85
Effects of juvenile isolation and morphine treatment on social interactions and opioid receptors in adult rats: behavioural and autoradiographic studies. Eur J Neurosci (1999) 0.85
Impairment of ketocyclazocine antinociception in rats by perinatal lead exposure. Toxicol Lett (1985) 0.85
Comparative binding of mu and delta selective ligands in whole brain and pons/medulla homogenates from rat: affinity profiles of fentanyl derivatives. Neuropharmacology (1988) 0.85
Preprodynorphin mediates locomotion and D2 dopamine and mu-opioid receptor changes induced by chronic 'binge' cocaine administration. J Neurochem (2007) 0.84
Ontogeny of catecholamine and GABA levels in rat brain: lack of effect of perinatal lead exposure. Toxicol Lett (1986) 0.84
Perinatal lead exposure alters the development of delta- but not mu-opioid receptors in rat brain. Br J Pharmacol (1988) 0.83
Assessment of the hot-plate antinociceptive test in mice. A new method for the statistical treatment of graded data. J Pharmacol Methods (1985) 0.82
The stereotypy-inducing and OCD-like effects of chronic 'binge' cocaine are modulated by distinct subtypes of nicotinic acetylcholine receptors. Br J Pharmacol (2012) 0.82
Differential effects of di-isopropylfluorophosphate poisoning and its treatment on opioid antinociception in the mouse. Life Sci (1983) 0.82
Differences in the effects of mu- and delta-opioid receptor antagonists upon plasma corticosterone levels in stressed mice. Eur J Pharmacol (1984) 0.81
Nociceptin/orphanin FQ knockout mice display up-regulation of the opioid receptor-like 1 receptor and alterations in opioid receptor expression in the brain. Neuroscience (2003) 0.81
Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats. Psychopharmacology (Berl) (1989) 0.81
Developmental modulation of cysteine conjugate beta-lyase/glutamine transaminase K/kynurenine aminotransferase mRNA in rat brain. Eur J Drug Metab Pharmacokinet (1998) 0.80
Characterisation of adenosine receptors mediating relaxation in hamster isolated aorta. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.80
Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets. Br J Pharmacol (1999) 0.79
Effects of adrenalectomy and hypophysectomy on enkephalin content of the rat hypothalamus. Br J Pharmacol (1980) 0.79
Effects of neonatal naltrindole treatment on antinociceptive and behavioral responses to mu and kappa agonists in rats. Pharmacol Biochem Behav (1999) 0.79
Involvement of functional antagonism in the effects of adenosine antagonists and L-NAME in the rat isolated heart. Gen Pharmacol (1997) 0.79
Enzyme potentiated hyposensitization: IV. effect of protamine on the immunological behavior of beta glucuronidase in mice and patients with hay fever. Ann Allergy (1975) 0.79
Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate). Br J Pharmacol (1982) 0.79
Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets. Biochem Pharmacol (1994) 0.78
Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta- or kappa-opioid receptor knockout mice. Neuroscience (2001) 0.78
Influence of maternal milk on functional activation of delta-opioid receptors in postnatal rats. J Pharmacol Exp Ther (2001) 0.78
Multiple opioid receptors mediate the respiratory depressant effects of fentanyl-like drugs in the rat. Gen Pharmacol (1990) 0.78
Desensitization of the guinea-pig urinary bladder by the enantiomers of adenylyl 5'-(beta, gamma-methylene)-diphosphonate and by substance P. Br J Pharmacol (1984) 0.78
Modification of an analgesy meter for paw-pressure antinociceptive testing in neonatal rats. J Pharmacol Methods (1984) 0.78
Mechanisms involved in the cardiovascular responses to opioid products of proenkephalin in the anaesthetised rat. Gen Pharmacol (1992) 0.77
Differential loss of biological activity of the enkephalins induced by current. Eur J Pharmacol (1981) 0.77
Characterisation of ADP receptors. Adv Exp Med Biol (1985) 0.77
Selective enhancement by an adenosine A1 receptor agonist of agents inducing contraction of the rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.77
Di-isopropylfluorophosphate induced antinociception and its interactions with opioid drugs in the rat. Toxicology (1986) 0.77
Developmental responses to opioids reveals a lack of effect on stress-induced corticosterone levels in neonatal rats. Br J Pharmacol (1987) 0.77
Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats. Neuropharmacology (1989) 0.77
The ontogenetic profiles of the pre- and postjunctional adenosine receptors in the rat vas deferens. Br J Pharmacol (1996) 0.77
Differential distribution of adenosine A2 receptors in the epididymal and prostatic portions of the rat vas deferens. Eur J Pharmacol (1996) 0.77
Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate. Biochem Pharmacol (1994) 0.77
Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene. Brain Res (2001) 0.77
Use of a newly developed technique to isolate rat pinealocytes and study the effects of adenosine agonists on melatonin production. J Pineal Res (1997) 0.77
Perinatal lead exposure impairs opioid but not non-opioid stress-induced antinociception in developing rats. Br J Pharmacol (1989) 0.76